Avadhut D Joshi
Overview
Explore the profile of Avadhut D Joshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
684
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Joshi S, Mittal A, Wang P, Joshi A, Vu E, Wang X
Int Immunopharmacol
. 2008 Jul;
8(9):1257-63.
PMID: 18602072
Previous studies from this laboratory have characterized RAW117-P murine large cell B-cell lymphoma and its in vivo selected highly malignant and liver metastatic RAW117-H10 subline for their biological and biochemical...
12.
Hegde G, Munger C, Emanuel K, Joshi A, Greiner T, Weisenburger D, et al.
Mol Cancer Ther
. 2008 Jun;
7(6):1450-60.
PMID: 18524848
Mantle cell lymphoma (MCL) has one of the worst clinical outcomes among the B-cell lymphomas, with a median survival of only 3 to 4 years. Therefore, a better understanding of...
13.
Joshi A, Clark E, Wang P, Munger C, Hegde G, Sanderson S, et al.
J Neuroimmune Pharmacol
. 2007 Nov;
2(2):202-12.
PMID: 18040845
Tumors of the nervous system, including neuroblastoma and glioblastoma, are difficult to treat with current therapies. Despite the advances in cancer therapeutics, the outcomes in these patients remain poor and,...
14.
Joshi A, Hegde G, Dickinson J, Mittal A, Lynch J, Eudy J, et al.
Clin Cancer Res
. 2007 Sep;
13(18 Pt 1):5295-304.
PMID: 17875758
Purpose: In B-cell chronic lymphocytic leukemia (CLL), high CD38 expression has been associated with unfavorable clinical course, advanced disease, resistance to therapy, shorter time to first treatment, and shorter survival....
15.
Mittal A, Hegde G, Aoun P, Bociek R, Dave B, Joshi A, et al.
Int J Mol Med
. 2007 Sep;
20(4):461-9.
PMID: 17786276
In B-cell chronic lymphocytic leukemia (CLL), Rai stage, immunoglobulin gene mutational status, chromosomal abnormalities, CD38 and ZAP-70 expression were used as prognostic markers. In this study, to understand the molecular...
16.
Joshi A, Dickinson J, Hegde G, Sanger W, Armitage J, Bierman P, et al.
Cancer Genet Cytogenet
. 2007 Jan;
172(2):120-6.
PMID: 17213020
B-cell chronic lymphocytic leukemia (B-CLL) is the most common B-cell leukemia among older populations in Western countries. The clinical course of B-CLL is heterogeneous: in some patients the disease course...
17.
Wang P, Munger C, Joshi A, Pirruccello S, Joshi S
Breast Cancer Res Treat
. 2004 Mar;
83(1):15-23.
PMID: 14997051
The Her2/neu oncogene encodes a transmembrane protein with homology to the epidermal growth factor receptor. Overexpression of this gene contributes to the aggressiveness of breast cancer and poor prognosis. Therefore,...